Autoimmunity stimulated by adoptively transferred dendritic cells is initiated by both αβ and γδ T cells but does not require MyD88 signaling

Journal of Immunology

Volumn 179, Issue 9, 2007, Pages 5819-5828

  Martin, David A ^a,c   Zhang, Kang ^a   Kenkel, Justin ^a   Hughes, Grant ^a   Clark, Edward ^a   Davidson, Anne ^b   Elkon, Keith B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HEPATITIS B ANTIBODY; HISTONE H1; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; ANTINUCLEAR ANTIBODY; DNA; LYMPHOCYTE ANTIGEN RECEPTOR; TOLL LIKE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; AUGMENTATION INDEX; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMORAL IMMUNITY; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYSTEMIC DISEASE; T LYMPHOCYTE; VACCINATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; CELL SURVIVAL; CHROMATIN; GENETICS; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNITY; CELL SURVIVAL; CHROMATIN; DENDRITIC CELLS; DNA; FEMALE; MICE; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 38449085427     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.9.5819     Document Type: Article

References (52)

1. Bondanza, A., V. S. Zimmermann, G. Dell'Antonio, E. Dal Cin, A. Capobianco, M. G. Sabbadini, A. A. Manfredi, and P. Rovere-Querini. 2003. Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J. Immunol. 170: 24-27.
2. Georgiev, M., L. M. Agle, J. L. Chu, K. B. Elkon, and D. Ashany. 2005. Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression. Arthritis Rheum. 52: 225-238.
3. Ehlers, M., H. Fukuyama, T. L. McGaha, A. Aderem, and J. V. Ravetch. 2006. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med. 203: 553-561.
4. Nimmerjahn, F., and J. V. Ravetch. 2005. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310: 1510-1512.
5. Bergtold, A., D. D. Desai, A. Gavhane, and R. Clynes. 2005. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23: 503-514.
6. Balazs, M., F. Martin, T. Zhou, and J. Kearney. 2002. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17: 341-352.
7. Dubois, B., B. Vanbervliet, J. Fayette, C. Massacrier, C. Van Kooten, F. Briere, J. Banchereau, and C. Caux. 1997. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185: 941-951.
8. Qi, H., J. G. Egen, A. Y. Huang, and R. N. Germain. 2006. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312: 1672-1676.
9. Rahman, A. H., and R. A. Eisenberg. 2006. The role of toll-like receptors in systemic lupus erythematosus. Springer Semin. Immunopathol. 28: 131-143.
10. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201: 723-735.
11. Martin, D. A., and K. B. Elkon. 2006. Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll-like receptor 9-independent pathway. Arthritis Rheum. 54: 951-962.
12. Gautier, G., M. Humbert, F. Deauvieau, M. Scuiller, J. Hiscott, E. E. Bates, G. Trinchieri, C. Caux, and P. Garrone. 2005. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 201: 1435-1446.
13. Napolitani, G., A. Rinaldi, F. Bertoni, F. Sallusto, and A. Lanzavecchia. 2005. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6: 769-776.
14. Baguet, A., J. Epler, K. W. Wen, and M. Bix. 2004. A Leishmania major response locus identified by interval-specific congenic mapping of a T helper type 2 cell bias-controlling quantitative trait locus. J. Exp. Med. 200: 1605-1612.
15. Peng, S. L., M. P. Madaio, A. C. Hayday, and J. Craft. 1996. Propagation and regulation of systemic autoimmunity by γδ T cells. J. Immunol. 157: 5689-5698.
16. Girardi, M., J. Lewis, E. Glusac, R. B. Filler, L. Geng, A. C. Hayday, and R. E. Tigelaar. 2002. Resident skin-specific γδ T cells provide local, nonredundant regulation of cutaneous inflammation. J. Exp. Med. 195: 855-867.
17. Arbuckle, M. R., M. T. McClain, M. V. Rubertone, R. H. Scofield, G. J. Dennis, J. A. James, and J. B. Harley. 2003. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349: 1526-1533.
18. Burlingame, R. W., R. L. Rubin, and A. M. Rosenberg. 1993. Autoantibodies to chromatin components in juvenile rheumatoid arthritis. Arthritis Rheum. 36: 836-841.
19. Hardin, J. A., and J. O. Thomas. 1983. Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B. Proc. Natl. Acad. Sci. USA 80: 7410-7414.
20. Portanova, J. P., R. E. Arndt, and B. L. Kotzin. 1988. Selective production of autoantibodies in graft-vs-host-induced and spontaneous murine lupus: predominant reactivity with histone regions accessible in chromatin. J. Immunol. 140: 755-760.
21. Zhou, Z., D. Ratliff, A. Suwa, M. Hirakata, Y. Bao, and J. A. Hardin. 2004. Are histone H1 variants initial triggers for humoral autoimmune responses to chromatin in lupus. Arthritis Rheum. 50: S220.
22. Burlingame, R. W., M. L. Boey, G. Starkebaum, and R. L. Rubin. 1994. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J. Clin. Invest. 94: 184-192.
23. Ramanujam, M., X. Wang, W. Huang, Z. Liu, L. Schiffer, H. Tao, D. Frank, J. Rice, B. Diamond, K. O. Yu, S. Porcelli, and A. Davidson. 2006. Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J. Clin. Invest. 116: 724-734.
24. Hahn, B. H. 1998. Antibodies to DNA. N. Engl. J. Med. 338: 1359-1368.
25. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
26. Yang, Y., C. T. Huang, X. Huang, and D. M. Pardoll. 2004. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat. Immunol. 5: 508-515.
27. Ronnblom, L., M. L. Eloranta, and G. V. Alm. 2006. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum. 54: 408-420.
28. Martin, D. A., and K. B. Elkon. 2005. Autoantibodies make a U-turn: the toll hypothesis for autoantibody specificity. J. Exp. Med. 202: 1465-1469.
29. Kaisho, T., and S. Akira. 2001. Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol. 22: 78-83.
30. Kim, S. J., D. Gershov, X. Ma, N. Brot, and K. B. Elkon. 2003. Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses. Ann. NY Acad. Sci. 987: 68-78.
31. Zhu, J., X. Liu, C. Xie, M. Yan, Y. Yu, E. S. Sobel, E. K. Wakeland, and C. Mohan. 2005. T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J. Clin. Invest. 115: 1869-1878.
32. Chen, M., Y. H. Wang, Y. Wang, L. Huang, H. Sandoval, Y. J. Liu, and J. Wang. 2006. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311: 1160-1164.
33. Evel-Kabler, K., X. T. Song, M. Aldrich, X. F. Huang, and S. Y. Chen. 2006. SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. J. Clin. Invest. 116: 90-100.
34. Jameson, J., D. Witherden, and W. L. Havran. 2003. T-cell effector mechanisms: γδ and CD1d-restricted subsets. Curr. Opin. Immunol. 15: 349-353.
35. Ferrick, D. A., M. D. Schrenzel, T. Mulvania, B. Hsieh, W. G. Ferlin, and H. Lepper. 1995. Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo. Nature 373: 255-257.
36. Brigl, M., and M. B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890.
37. Yang, J. Q., T. Chun, H. Liu, S. Hong, H. Bui, L. Van Kaer, C. R. Wang, and R. R. Singh. 2004. CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice. Eur. J. Immunol. 34: 1723-1732.
38. Brandes, M., K. Willimann, and B. Moser. 2005. Professional antigen-presentation function by human γδ T Cells. Science 309: 264-268.
39. Akbari, O., and D. T. Umetsu. 2004. Role of regulatory dendritic cells in allergy and asthma. Curr. Opin. Allergy Clin. Immunol. 4: 533-538.
40. Liu, Y. J., V. Soumelis, N. Watanabe, T. Ito, Y. H. Wang, R. D. Malefyt, M. Omori, B. Zhou, and S. F. Ziegler. 2007. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu. Rev. Immunol. 25: 193-219.
41. Loser, K., A. Mehling, S. Loeser, J. Apelt, A. Kuhn, S. Grabbe, T. Schwarz, J. M. Penninger, and S. Beissert. 2006. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 12: 1372-1379.
42. Ohnishi, K., F. M. Ebling, B. Mitchell, R. R. Singh, B. H. Hahn, and B. P. Tsao. 1994. Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. Int. Immunol. 6: 817-830.
43. Theofilopoulos, A. N., R. Baccala, B. Beutler, and D. H. Kono. 2005. Type I interferons (α/β) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336.
44. Pisitkun, P., J. A. Deane, M. J. Difilippantonio, T. Tarasenko, A. B. Satterthwaite, and S. Bolland. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312: 1669-1672.
45. Subramanian, S., K. Tus, Q. Z. Li, A. Wang, X. H. Tian, J. Zhou, C. Liang, G. Bartov, L. D. McDaniel, X. J. Zhou, R. A. Schultz, and E. K. Wakeland. 2006. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103: 9970-9975.
46. -/- mice. J. Exp. Med. 195: 1167-1174.
47. Nishimura, H., M. Nose, H. Hiai, N. Minato, and T. Honjo. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11: 141-151.
48. Lang, K. S., P. Georgiev, M. Recher, A. A. Navarini, A. Bergthaler, M. Heikenwalder, N. L. Harris, T. Junt, B. Odermatt, P. A. Clavien, et al. 2006. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J. Clin. Invest. 116: 2456-2463.
49. Lang, K. S., M. Recher, T. Junt, A. A. Navarini, N. L. Harris, S. Freigang, B. Odermatt, C. Conrad, L. M. Ittner, S. Bauer, et al. 2005. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 11: 138-145.
50. Pawar, R. D., P. S. Patole, A. Ellwart, M. Lech, S. Segerer, D. Schlondorff, and H. J. Anders. 2006. Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis. J. Am. Soc. Nephrol. 17: 3365-3373.
51. Gavin, A. L., K. Hoebe, B. Duong, T. Ota, C. Martin, B. Beutler, and D. Nemazee. 2006. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314: 1936-1938.
52. + T cell populations lacking helper function. Nat. Immunol. 6: 163-170.